Accellacare - Wilmington — Wilmington, North Carolina

Accellacare - Wilmington is a clinical research site located in Wilmington, North Carolina, United States 28401.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Accellacare - Wilmington has participated in 28 clinical trials with 10 currently active.

Therapeutic areas: Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Type 2 Diabetes Mellitus.

Sponsors: Eli Lilly and Company, Pfizer, BioNTech SE.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare - Wilmington?

Accellacare - Wilmington has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare - Wilmington conducted?

Accellacare - Wilmington has 28 clinical trials on record, with 10 currently active. Their work covers Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Type 2 Diabetes Mellitus.

Is Accellacare - Wilmington accredited by Crixeo Health?

Yes — Accellacare - Wilmington holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Accellacare - Wilmington?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.